Skip to main content
Journal of Experimental Orthopaedics

Table 1 PRP ratio in PRP + Visipaque270® and PRP + Iopamiron200® at different incubation delays

From: Iodine contrast agents do not influence Platelet-Rich Plasma function at an early time point in vitro

Incubation Delay (mn)

PRP ratio

Visipaque270® (n = 58)

Iopamiron200® (n = 69)

5

0.902 ± 0.028

0.916 ± 0.009

10

0.814 ± 0.014

0.905 ± 0.026

15

0.909 ± 0.020

0.910 ± 0.018

20

0.921 ± 0.025

0.894 ± 0.018

30

0.900 ± 0.028

0.923 ± 0.020

  1. NOTE: PRP ratio is defined as the concentration in PRP in the mixture at each incubation delay divided by the initial concentration in PRP. Results are mean ± sd
Back to article page